Selected Grants
1/3 CTSA UM1 at Duke University
ResearchCo-Core Leader · Awarded by National Institutes of Health · 2025 - 2032Transdisciplinary Research in Infectious Diseases to Engage Third-year medical students (TRIDENT) R25
Inst. Training Prgm or CMEInvestigator · Awarded by National Institutes of Health · 2025 - 2030Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2030Pharmacists for Prevention (P4P): Harnessing the role of pharmacists in ending the HIV epidemic through collaboration with minority-serving pharmacy schools.
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2030Regional AIDS Education and Training Centers
Inst. Training Prgm or CMEProgram Director · Awarded by Vanderbilt University Medical Center · 2015 - 2029Quantitative Methods for HIV/AIDS Research
Inst. Training Prgm or CMESteering Committee Member · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2028Mechanisms of HIV persistence in the kidney (R01)
ResearchInvestigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2022 - 2027Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach (R01)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027Evidence2Practice (E2P): A PrEP Capacity Building and HIV Workforce Development Initiative
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by ViiV Healthcare · 2025 - 2027EJAF HIV CME Training Development
ResearchCo Investigator · Awarded by Elton John AIDS Foundation · 2022 - 2026RFTOP 2022 Domain 5-E003 Strategic Use of Race, Ethnicity, and Social Determinants of Health Data in National Healthcare Safety Network (NHSN) Measures to Promote Health Equity
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2022 - 2025Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2025Understanding the Intersectional Discrimination Experiences of Young Black Men who Have Sex with Men and their Sexual Health
FellowshipCollaborator · Awarded by National Institutes of Health · 2024 - 2025REPRIEVE Extension for Trial Completion
Clinical TrialPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2024Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - SAB
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2021 - 2024Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401))
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2020 - 2024Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Sagent Camostat
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2021 - 2024Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Astrazeneca
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2021 - 2024Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Brii
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2021 - 2024Bridging the Gap to Enhance Clinical Research Program (BIGGER)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023The development and validation of a scale to measure Treatment Regimen Fatigue among older adults living with HIV
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2023Evidence2Practice: Leveraging implementation science to recruit HBCU/MSI students into careers in HIV research (CFAR CDEIPI Supplement)
ResearchPrincipal Investigator · Awarded by The George Washington University · 2021 - 2023Randomized Trial to Prevent Vascular Events in HIV- REPRIEVE (A5332)
Clinical TrialCo Investigator · Awarded by Massachusetts General Hospital · 2015 - 2023Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Synairgen
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2022 - 2023A Multidisciplinary Approach to Primary Cardiovascular Disease Prevention in HIV-infected (K23)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022Adapt Out COVID (ACTIV-2/A5401) - BMS
Clinical TrialPrincipal Investigator · Awarded by PPD Investigator Services, LLC · 2021 - 2022A nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention (EXTRA-CVD)
ResearchCo Investigator · Awarded by Case Western Reserve University · 2018 - 2021Bringing PrEP to Campus: Examining Strategies for PrEP Delivery to Historically Black College and Universities (HBCU)
ResearchProject Co-Lead · Awarded by National Institutes of Health · 2005 - 20206510 HIV-HCV SWITCH - (337-1834)
ResearchPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2016 - 2019Systems Biology Approaches for Predicting Cardiometabolic Risk in Persons Living with HIV
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2018External Relationships
- Gilead Sciences, Inc.
- National Institutes of Health (NIH)
- Viiv (GlaxoSmithKline)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.